Tag Archives: NASDAQ:BMRN

Analysts Offer Insights on Healthcare Companies: BioMarin (NASDAQ: BMRN), Alnylam Pharma (NASDAQ: ALNY) and Emergent Biosolutions (NYSE: EBS)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin (BMRN – Research Report), Alnylam Pharma (ALNY – Research Report) and Emergent Biosolutions (EBS – Research Report). BioMarin (BMRN) Cowen & Co.

Cantor Fitzgerald Sticks to Its Buy Rating for BioMarin (BMRN)

In a report released today, Eliana Merle from Cantor Fitzgerald maintained a Buy rating on BioMarin (BMRN – Research Report), with a price target of $126. The company’s shares opened today at $87.58. Merle said: “The Disclosure Section may be

Oppenheimer Initiates a Hold Rating on BioMarin (BMRN)

Oppenheimer analyst Leland Gershell initiated coverage with a Hold rating on BioMarin (BMRN – Research Report) today and set a price target of $92. The company’s shares opened today at $94.94. Gershell commented: “We are initiating coverage of BMRN with

BioMarin (BMRN) Received its Third Buy in a Row

After Cowen & Co. and J.P. Morgan gave BioMarin (NASDAQ: BMRN) a Buy rating last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Eliana Merle reiterated a Buy rating on BioMarin yesterday and set a price

Analysts Offer Insights on Healthcare Companies: BioMarin (NASDAQ: BMRN) and Trillium Therapeutics (NASDAQ: TRIL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin (BMRN – Research Report) and Trillium Therapeutics (TRIL – Research Report) with bullish sentiments. BioMarin (BMRN) In a report released today,

Analysts Are Bullish on These Healthcare Stocks: BioMarin (BMRN), Rocket Pharmaceuticals Inc (RCKT)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioMarin (BMRN – Research Report) and Rocket Pharmaceuticals Inc (RCKT – Research Report) with bullish sentiments. BioMarin (BMRN) In a report released